Literature DB >> 30682892

The role of chronic kidney disease-associated dysbiosis in cardiovascular disease.

Mark A Bryniarski1, Fares Hamarneh2,3, Rabi Yacoub3.   

Abstract

IMPACT STATEMENT: Negative alterations, or dysbiosis, in the intestinal microbial community balance in response to chronic kidney disease is emerging as a substantial and important factor in inducing and exacerbating multiple comorbid conditions. Patients with renal insufficiency experience a substantial increase in cardiovascular risk, and recent evidence is shedding light on the close interaction between microbiome dysbiosis and increased cardiovascular events in this population. Previous association and recent causality studies utilizing experimental animal models have enriched our understanding and confirmed the impact of microbial community imbalance on cardiac health in both the general population and in patients with renal impairment.

Entities:  

Keywords:  Chronic kidney disease; cardiovascular disease; dysbiosis; hypertension; microbiome; uremic toxins

Mesh:

Year:  2019        PMID: 30682892      PMCID: PMC6547008          DOI: 10.1177/1535370219826526

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  184 in total

Review 1.  Commensal host-bacterial relationships in the gut.

Authors:  L V Hooper; J I Gordon
Journal:  Science       Date:  2001-05-11       Impact factor: 47.728

Review 2.  Structure of the intestinal flora responsible for development of the gut immune system in a rodent model.

Authors:  Y Umesaki; H Setoyama
Journal:  Microbes Infect       Date:  2000-09       Impact factor: 2.700

3.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

4.  Chronic renal failure-induced changes in serum and urine bile acid profiles.

Authors:  F Jimenez; M J Monte; M Y El-Mir; M J Pascual; J J G Marin
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

Review 5.  Adaptation of bacteria to the intestinal niche: probiotics and gut disorder.

Authors:  C Dunne
Journal:  Inflamm Bowel Dis       Date:  2001-05       Impact factor: 5.325

6.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Authors:  L Y Agodoa; L Appel; G L Bakris; G Beck; J Bourgoignie; J P Briggs; J Charleston; D Cheek; W Cleveland; J G Douglas; M Douglas; D Dowie; M Faulkner; A Gabriel; J Gassman; T Greene; Y Hall; L Hebert; L Hiremath; K Jamerson; C J Johnson; J Kopple; J Kusek; J Lash; J Lea; J B Lewis; M Lipkowitz; S Massry; J Middleton; E R Miller; K Norris; D O'Connor; A Ojo; R A Phillips; V Pogue; M Rahman; O S Randall; S Rostand; G Schulman; W Smith; D Thornley-Brown; C C Tisher; R D Toto; J T Wright; S Xu
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

7.  The effect of a model melanoidin mixture on faecal bacterial populations in vitro.

Authors:  J M Ames; A Wynne; A Hofmann; S Plos; G R Gibson
Journal:  Br J Nutr       Date:  1999-12       Impact factor: 3.718

Review 8.  Contribution of microbial amino acids to amino acid homeostasis of the host.

Authors:  C C Metges
Journal:  J Nutr       Date:  2000-07       Impact factor: 4.798

9.  Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

Authors:  C J Sinal; M Tohkin; M Miyata; J M Ward; G Lambert; F J Gonzalez
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

Review 10.  How host-microbial interactions shape the nutrient environment of the mammalian intestine.

Authors:  Lora V Hooper; Tore Midtvedt; Jeffrey I Gordon
Journal:  Annu Rev Nutr       Date:  2002-04-04       Impact factor: 11.848

View more
  8 in total

1.  Microbiome: Our opponents or allies in healthcare and medicine.

Authors:  Horst A von Recum
Journal:  Exp Biol Med (Maywood)       Date:  2019-03-25

2.  A Summary of the Fourth Annual Virology Education HIV Microbiome Workshop.

Authors:  Brett Williams; Mimi Ghosh; Charles Boucher; Frederic Bushman; Stacy Carrington-Lawrence; Ronald G Collman; Satya Dandekar; Que Dang; Angela Malaspina; Roger Paredes; Cara Wilson; Sandra Pinto Cardoso; Laurel Lagenaur; Jessica Santos; Christopher Joy; Alan Landay
Journal:  AIDS Res Hum Retroviruses       Date:  2020-03-09       Impact factor: 2.205

3.  Unconjugated p-cresol activates macrophage macropinocytosis leading to increased LDL uptake.

Authors:  Lee D Chaves; Sham Abyad; Amanda M Honan; Mark A Bryniarski; Daniel I McSkimming; Corrine M Stahura; Steven C Wells; Donna M Ruszaj; Marilyn E Morris; Richard J Quigg; Rabi Yacoub
Journal:  JCI Insight       Date:  2021-06-08

4.  Effect of Added Dietary Betaine and Soluble Fiber on Metabolites and Fecal Microbiome in Dogs with Early Renal Disease.

Authors:  Eden Ephraim; Dennis E Jewell
Journal:  Metabolites       Date:  2020-09-15

Review 5.  Cardiac Autonomic Neuropathy: A Progressive Consequence of Chronic Low-Grade Inflammation in Type 2 Diabetes and Related Metabolic Disorders.

Authors:  Nour-Mounira Z Bakkar; Haneen S Dwaib; Souha Fares; Ali H Eid; Yusra Al-Dhaheri; Ahmed F El-Yazbi
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

Review 6.  Microbiota medicine: towards clinical revolution.

Authors:  Prisca Gebrayel; Carole Nicco; Souhaila Al Khodor; Jaroslaw Bilinski; Elisabetta Caselli; Elena M Comelli; Markus Egert; Cristina Giaroni; Tomasz M Karpinski; Igor Loniewski; Agata Mulak; Julie Reygner; Paulina Samczuk; Matteo Serino; Mariusz Sikora; Annalisa Terranegra; Marcin Ufnal; Romain Villeger; Chantal Pichon; Peter Konturek; Marvin Edeas
Journal:  J Transl Med       Date:  2022-03-07       Impact factor: 5.531

Review 7.  The Emerging Role of Metabolism in Brain-Heart Axis: New Challenge for the Therapy and Prevention of Alzheimer Disease. May Thioredoxin Interacting Protein (TXNIP) Play a Role?

Authors:  Lorena Perrone; Mariarosaria Valente
Journal:  Biomolecules       Date:  2021-11-08

Review 8.  Thrombolome and Its Emerging Role in Chronic Kidney Diseases.

Authors:  Justyna Fryc; Beata Naumnik
Journal:  Toxins (Basel)       Date:  2021-03-18       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.